Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Integrated breast cancer genomics.

Henrik Edgren1, Olli Kallioniemi

  • 1Medical Biotechnology Centre, VTT Technical Research Centre of Finland and University of Turku, 20521 Turku, Finland.

Cancer Cell
|December 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemia.

Nature·2026
Same author

A multi-center study on the consistency of drug sensitivity testing in patients with acute myeloid leukemia.

NPJ precision oncology·2026
Same author

Midostaurin response in AML is shaped by a progenitor-like cell state selectively targeted by SMAC mimetics.

NPJ precision oncology·2026
Same author

Landscape of circular RNAs in acute myeloid leukemia and their clinical significance.

NPJ precision oncology·2026
Same author

Tumor cell FAP orchestrates EMT and immune suppression in aggressive localized ccRCC.

Theranostics·2026
Same author

Validation of fibroblast activation protein and α-smooth muscle actin as prognostic biomarkers in prostate cancer through AI-assisted image analysis of dual-marker IHC.

The journal of pathology. Clinical research·2025

Predicting breast cancer patient survival and therapy response is challenging. Integrated genomic and transcriptomic analysis of tumors and cell lines offers new therapeutic targets and prognostic biomarkers for breast cancer.

Area of Science:

  • Oncology
  • Genomics
  • Transcriptomics

Background:

  • Predicting breast cancer patient survival and therapy response remains a significant clinical challenge.
  • Integrated analysis of genomic and transcriptomic profiles from primary tumors and cell lines is crucial for advancing breast cancer research.

Discussion:

  • Molecular profiling of 145 primary breast cancers and 51 cell lines revealed disease mechanisms.
  • Identified potential therapeutic targets and prognostic biomarkers from clinical tumor data.

Key Insights:

  • A comprehensive cell line resource enables exploration of cellular responses to various therapies.
  • Integrated molecular profiling provides insights into breast cancer heterogeneity and progression.

Outlook:

Related Experiment Videos

  • These findings pave the way for improved diagnostic tools and personalized therapeutic strategies in breast cancer.
  • Future research can leverage integrated profiling to significantly impact clinical decision-making for breast cancer patients.